本页面由Tiger Trade Technology Pte. Ltd.提供服务

Acumen Pharmaceuticals, Inc.

2.51
+0.02000.80%
盘后2.45-0.0600-2.39%18:59 EDT
成交量:39.64万
成交额:101.13万
市值:1.81亿
市盈率:-1.36
高:2.60
开:2.50
低:2.49
收:2.49
52周最高:3.60
52周最低:0.9901
股本:7,221.28万
流通股本:4,091.36万
量比:0.95
换手率:0.97%
股息:- -
股息率:- -
每股收益(TTM):-1.8498
每股收益(LYR):-2.0035
净资产收益率:-93.23%
总资产收益率:-42.37%
市净率:2.07
市盈率(LYR):-1.25

数据加载中...

2026/05/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/12

重要事件披露

Form 8-K - Current report
2026/04/08

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/31

SEC问询函

Form CORRESP - Correspondence
2026/03/26

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/26

重要事件披露

Form 8-K - Current report
2026/03/16

重要事件披露

Form 8-K - Current report
2026/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities